Sign up to save your podcasts
Or
Share Discussing the Role of MRD in CLL With Talal Hilal, MD
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Discussing the Role of MRD in CLL With Talal Hilal, MD
Dr. Hilal, of the Mayo Clinic, joins Chadi Nabhan, MD, MBA, FACP, on “The HemOnc Pulse” to discuss measurable residual disease (MRD) and the debates surrounding its use for response assessment in patients with chronic lymphocytic leukemia (CLL).
View all episodes
By Rahul Banerjee, MD
4.8
2727 ratings
Dr. Hilal, of the Mayo Clinic, joins Chadi Nabhan, MD, MBA, FACP, on “The HemOnc Pulse” to discuss measurable residual disease (MRD) and the debates surrounding its use for response assessment in patients with chronic lymphocytic leukemia (CLL).
More shows like The HemOnc Pulse
View all
JAMA Editors' Summary
138 Listeners
NEJM This Week
323 Listeners
JAMA Clinical Reviews
498 Listeners
Hematologic Oncology Update
76 Listeners
Research To Practice | Oncology Videos
121 Listeners
The Hematologist
28 Listeners
Core IM | Internal Medicine Podcast
1,145 Listeners
OncoPharm
187 Listeners
OncLive® On Air
22 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
369 Listeners
Blood Podcast
52 Listeners
Healthcare Unfiltered
138 Listeners
Blood Cancer Talks
48 Listeners
Two Onc Docs
193 Listeners
WolverHeme Happy Hour
29 Listeners